CDNA CareDx Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: CDNA

Price (delayed)

$19.01

Market cap

$990.11M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.41

Enterprise value

$923.12M

CareDx, Inc., headquartered in South San Francisco, California, is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant ...

Highlights
The debt has declined by 16% year-on-year and by 4.9% since the previous quarter
CareDx's net income has plunged by 127% YoY but it has increased by 3.7% from the previous quarter
CareDx's EPS has plunged by 124% YoY but it has increased by 3.7% from the previous quarter
The equity has decreased by 39% YoY
CDNA's gross profit is down by 17% year-on-year and by 2.9% since the previous quarter
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://www.caredx.com
Peers: TTOO AGIO ARDX

Key stats

What are the main financial stats of CDNA
Market
Shares outstanding
52.08M
Market cap
$990.11M
Enterprise value
$923.12M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
3.84
Price to sales (P/S)
3.57
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.36
Earnings
Revenue
$275.11M
EBIT
-$195.35M
EBITDA
-$175.06M
Free cash flow
-$41.43M
Per share
EPS
-$3.41
Free cash flow per share
-$0.8
Book value per share
$4.95
Revenue per share
$5.32
TBVPS
$7.13
Balance sheet
Total assets
$452.41M
Total liabilities
$196.18M
Debt
$26.89M
Equity
$256.23M
Working capital
$232.88M
Liquidity
Debt to equity
0.1
Current ratio
4.32
Quick ratio
3.94
Net debt/EBITDA
0.38
Margins
EBITDA margin
-63.6%
Gross margin
62.9%
Net margin
-66.6%
Operating margin
-72.1%
Efficiency
Return on assets
-37.9%
Return on equity
-55.6%
Return on invested capital
-72.8%
Return on capital employed
-51.1%
Return on sales
-71%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CDNA stock price

How has the CareDx stock price performed over time
Intraday
0.74%
1 week
5.09%
1 month
35.69%
1 year
68.83%
YTD
58.42%
QTD
22.41%

Financial performance

How have CareDx's revenue and profit performed over time
Revenue
$275.11M
Gross profit
$173.14M
Operating income
-$198.38M
Net income
-$183.19M
Gross margin
62.9%
Net margin
-66.6%
CareDx's operating margin has plunged by 179% YoY
The net margin has dropped by 163% year-on-year
The operating income has dropped by 140% year-on-year but it rose by 2.5% since the previous quarter
CareDx's net income has plunged by 127% YoY but it has increased by 3.7% from the previous quarter

Growth

What is CareDx's growth rate over time

Valuation

What is CareDx stock price valuation
P/E
N/A
P/B
3.84
P/S
3.57
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.36
CareDx's EPS has plunged by 124% YoY but it has increased by 3.7% from the previous quarter
The stock's price to book (P/B) is 124% more than its last 4 quarters average of 1.7 but 29% less than its 5-year quarterly average of 5.4
The equity has decreased by 39% YoY
The price to sales (P/S) is 97% more than the last 4 quarters average of 1.8 but 51% less than the 5-year quarterly average of 7.3
The revenue has decreased by 14% YoY

Efficiency

How efficient is CareDx business performance
The ROE has plunged by 199% YoY and by 8% from the previous quarter
CareDx's ROS has plunged by 163% YoY
The ROIC has shrunk by 159% YoY and by 5% QoQ
CDNA's return on assets has dropped by 153% year-on-year

Dividends

What is CDNA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CDNA.

Financial health

How did CareDx financials performed over time
The company's total assets is 131% higher than its total liabilities
CareDx's total liabilities has soared by 81% YoY but it has decreased by 4.5% from the previous quarter
The company's quick ratio fell by 18% YoY but it rose by 7% QoQ
The debt is 90% smaller than the equity
The equity has decreased by 39% YoY
CareDx's debt to equity has increased by 25% YoY but it has decreased by 9% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.